Protein expression changes in ovarian cancer during the transition from benign to malignant

Journal of Proteome Research

Volumn 11, Issue 5, 2012, Pages 2876-2889

  Waldemarson, Sofia ^a   Krogh, Morten ^a   Alaiya, Ayodele ^c   Kirik, Ufuk ^a   Schedvins, Kjell ^d   Auer, Gert ^d   Hansson, Karin M ^a   Ossola, Reto ^b   Aebersold, Ruedi ^b,e   Lee, Hookeun ^b,f   Malmström, Johan ^a   James, Peter ^a  

^a LUND UNIVERSITY   (Sweden)

^b ETH ZURICH   (Switzerland)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f Gachon University   (South Korea)

Author keywords

biomarker; epithelial ovarian cancer (EOC); Ingenuity pathway analysis; iTRAQ; mass spectrometry; multiple reaction monitoring (MRM); proteomics; selected reaction monitoring (SRM)

Indexed keywords

ARTICLE; BENIGN TUMOR; DISEASE SEVERITY; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

14-3-3 PROTEINS; AMINO ACID SEQUENCE; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEOME; PROTEOMICS; ROC CURVE; SEQUENCE ANALYSIS, PROTEIN; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84860603290     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr201258q     Document Type: Article

References (34)

1. Gadducci, A. Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature Int. J. Gynecol. Cancer 2007, 17, 21-31
2. Jacobs, I. J.; Menon, U. Progress and challenges in screening for early detection of ovarian cancer Mol. Cell. Proteomics 2004, 3, 355-366
3. Corney, D. C.; Flesken-Nikitin, A.; Choi, J.; Nikitin, A. Y. Role of p53 and Rb in ovarian cancer Adv. Exp. Med. Biol. 2008, 622, 99-117
4. Kurman, R. J.; Shih, I.-M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer - shifting the paradigm Hum. Pathol. 2011, 42, 918-931
5. Bengtsson, S. Large-scale proteomics analysis of human ovarian cancer for biomarkers J. Proteome Res. 2007, 6, 1440-1450
6. Gygi, S. P. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags Nat. Biotechnol. 1999, 17, 994-999
7. Ross, P. L. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents Mol. Cell. Proteomics 2004, 3, 1154-1169
8. Ong, S.-E. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics Mol. Cell. Proteomics 2002, 1, 376-386
9. Thompson, A. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS Anal. Chem. 2003, 75, 1895-1904
10. Häkkinen, J.; Vincic, G.; Maisnsson, O.; Warell, K.; Levander, F. The proteios software environment: an extensible multiuser platform for management and analysis of proteomics data J. Proteome Res. 2009, 8, 3037-3043
11. Levander, F. Automated reporting from gel-based proteomics experiments using the open source Proteios database application Proteomics 2007, 7, 668-674
12. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry Nat. Methods 2007, 4, 207-214
13. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74, 5383-5392
14. Keller, A.; Eng, J.; Zhang, N.; Li, X. J.; Aebersold, R. A uniform proteomics MS/MS analysis platform utilizing open XML file formats Mol. Syst. Biol. 2005, 1 (2005) 0017
15. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75, 4646-4658
16. Ihaka, R.a.G., R. R: A language for data analysis and graphics J. Comput. Gr. Stat. 1996, 5, 299-314
17. Picotti, P. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes Nat. Methods 2010, 7, 43-46
18. Ndozangue-Touriguine, O.; Hamelin, J.; Breard, J. Cytoskeleton and apoptosis. Biochem. Pharmacol. 2008, not supplied.
19. Cheretis, C. Expression of ERp29, an endoplasmic reticulum secretion factor in basal-cell carcinoma Am. J. Dermatopathol. 2006, 28, 410-412
20. Xing, X.; Lai, M.; Wang, Y.; Xu, E.; Huang, Q. Overexpression of glucose-regulated protein 78 in colon cancer Clin. Chim. Acta: Int. J. Clin. Chem. 2006, 364, 308-315
21. Gregory-Bass, R. C. Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis Int. J. Cancer 2008, 122, 1923-1930
22. Kirkegaard, T. AKT activation predicts outcome in breast cancer patients treated with tamoxifen J. Pathol. 2005, 207, 139-146
23. Saal, L. H. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair Nat. Genet. 2008, 40, 102-107
24. Asano, T. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells Oncogene 2004, 23, 8571-8580
25. Campbell, I. G. Mutation of the PIK3CA gene in ovarian and breast cancer Cancer Res. 2004, 64, 7678-7681
26. Campbell, I. G.; Russell, S. E.; Phillips, W. A. PIK3CA mutations in ovarian cancer Clin. Cancer Res. 2005, 11, 7042; author reply 7043-7043
27. Mayo, L. D.; Donner, D. B. The PTEN, Mdm2, p53 tumor suppressor- oncoprotein network Trends Biochem. Sci. 2002, 27, 462-467
28. Okamoto, A. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer Cancer Res. 1991, 51, 5171-5176
29. Dohmoto, K. The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines Int. J. Cancer 2001, 91, 468-473
30. Yaffe, M. B. The structural basis for 14-3-3:phosphopeptide binding specificity Cell 1997, 91, 961-971
31. He, Y.; Wu, X.; Liu, X.; Yan, G.; Xu, C. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker J. Proteome Res. 2010, 9, 6180-6190
32. May, D. Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer Oncogene 2005, 24, 1011-1020
33. de la Rosa, G.; Yang, D.; Tewary, P.; Varadhachary, A.; Oppenheim, J. J. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses J. Immunol. 2008, 180, 6868-6876
34. Lee, S.-H.; Pyo, C.-W.; Hahm, D. H.; Kim, J.; Choi, S.-Y. Iron-saturated lactoferrin stimulates cell cycle progression through PI3K/Akt pathway Mol. Cells 2009, 28, 37-42